{"id":"https://openalex.org/W1966408042","doi":"https://doi.org/10.1097/00004850-199300810-00005","title":"A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms","display_name":"A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms","alternate_titles":[],"publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W1966408042","doi":"https://doi.org/10.1097/00004850-199300810-00005","mag":"1966408042","pmid":"https://pubmed.ncbi.nlm.nih.gov/8097214"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199300810-00005","doi":"https://doi.org/10.1097/00004850-199300810-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300810-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966408042"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108285762","display_name":"MALCOLM H. LADER","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Lader","raw_affiliation_strings":["Institute of Psychiatry, Denmark Hill, London, UK","Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, Denmark Hill, London, UK","institution_ids":[]},{"raw_affiliation_string":"Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076358602","display_name":"Ibrahim Farr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Farr","raw_affiliation_strings":["Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"S. Morton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Morton","raw_affiliation_strings":["Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2745,"has_fulltext":false,"cited_by_count":19,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.49884903,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"8","issue":"1","first_page":"31","last_page":"36"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.3617999851703644,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.3617999851703644,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.2443999946117401,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.04650000110268593,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpidem","display_name":"alpidem","score":0.9909999966621399},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.8519999980926514},{"id":"https://openalex.org/keywords/benzodiazepine-tapering","display_name":"benzodiazepine tapering","score":0.7870000004768372},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.5669999718666077},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.7590000033378601},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.7110000252723694},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7863441705703735},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6916226744651794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5876538157463074},{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.5762914419174194},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3697839081287384},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3202349841594696},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30243760347366333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1626458466053009},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.15872815251350403},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.05638691782951355},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199300810-00005","doi":"https://doi.org/10.1097/00004850-199300810-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300810-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:8097214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8097214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2036895589","https://openalex.org/W2035384587","https://openalex.org/W2335780156","https://openalex.org/W2091919635","https://openalex.org/W2108608442","https://openalex.org/W1996454411","https://openalex.org/W1977664713","https://openalex.org/W2108305235","https://openalex.org/W2136792946","https://openalex.org/W2059204867"],"abstract_inverted_index":{"Chronic":[0],"normal-dose":[1],"benzodiazepine":[2,37,65,137],"users":[3],"requesting":[4],"drug":[5],"withdrawal":[6,90,138],"were":[7,78,92],"allocated":[8],"to":[9,80,152],"substitution":[10],"with":[11,103],"either":[12],"the":[13,26,31,34,42,64,116,120],"new":[14],"anxiolytic":[15],"alpidem":[16,51,70,75,117,127],"(n":[17,22],"=":[18,23],"13)":[19],"or":[20,56,71,76],"placebo":[21,57,72,77,99,121],"12).":[24],"During":[25],"first":[27],"2":[28,44],"weeks":[29,45,60],"of":[30,36,95,105,141],"tapering":[32],"programme,":[33],"dose":[35],"was":[38,47,66,124],"kept":[39],"constant;":[40],"for":[41,59],"next":[43,74],"it":[46],"halved":[48],"and":[49,62,68,82,88,110],"half-dose":[50,81],"(25":[52],"mg":[53],"twice":[54],"daily)":[55],"substituted;":[58],"5":[61],"6,":[63],"discontinued":[67],"full-dose":[69],"given;":[73],"tapered":[79],"then":[83],"finally":[84],"discontinued.":[85],"Regular":[86],"anxiety":[87],"tranquillizer":[89],"ratings":[91],"made.":[93],"Nine":[94],"12":[96],"patients":[97,133],"given":[98],"withdrew":[100],"successfully":[101],"compared":[102],"four":[104],"13":[106],"alpidem-treated":[107],"patients.":[108,122],"Anxiety":[109],"other":[111],"symptom":[112],"levels":[113],"increased":[114],"in":[115,131],"but":[118],"not":[119,129],"It":[123],"concluded":[125],"that":[126],"is":[128],"helpful":[130],"helping":[132],"withdrawing":[134],"from":[135],"a":[136,149],"perhaps":[139],"because":[140],"partial":[142],"agonist":[143],"properties.":[144],"These":[145],"actions":[146],"may":[147],"imply":[148],"lesser":[150],"propensity":[151],"induce":[153],"dependence":[154],"on":[155],"long-term":[156],"use.":[157]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966408042","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
